1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6353B5D6C49B14E13852576B800205BC0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/supporting-successful-diabetes-product-launches-tactics-for-educating-physicians?opendocument
18
19opendocument
2054.226.175.101
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Market Entry: Metabolic and Cardiovascular Diseases

Supporting Successful Diabetes Product Launches: Tactics for Educating Physicians

ID: 5072


Features:

24 Info Graphics

16 Data Graphics

200+ Metrics

6 Narratives


Pages/Slides: 55


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Diabetes Product Launches: Tactics for Educating Physicians"


Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents.

Study Overview

Educating the marketplace about a new product is a vital prerequisite for both a therapy's launch and the critical first years on the market. Physicians in particular are an important focal point of the market education process because they are both prescribers and influencers and are thus a key way that organizations seek to gain a firm foothold in the marketplace. This study examines a number of issues that revolve around physician education tactics and strategies - for diabetes as well as other product types. This field research and benchmarking study also presents benchmarks around types and timing of physician education activities, publication productivity, CME preferences and prevalence and new technology approaches. Executives, especially those working in the diabetes therapeutic area, can use this research to compare their physician education strategies and tactics with those of leading organizations.

Key Topics

  • Summary of Key Insights, Findings and Lessons Learned
  • Research Participants, Launch Experience, and Therapeutic Area Demographics
  • Market Entry Success Drivers
  • Voices From the Field: Best Practices, Lessons Learned & Pitfalls To Consider
  • Future Trends & Issues

Sample Key Metrics
  • Timing of Publishing Various Data Types for Physician Education
  • Rating of Importance of Publishing Clinical Results in Various Channels
  • Number of Publications (by type) Expect to Issue Phase III to Launch
  • Top Five Activities for Educating Physicians
  • Timing of Various Physician Education Activities
  • Provision of CME Grants by Program Type for Products/TAs Pre-Launch
  • Ranking of Most Effective New Technologies for Educating Physicians


Methodology

Research was conducted through surveys and interviews. Research participants included 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies. Diabetes/Cardiovascular research participants included 11 executives and managers at 11 different industry leading companies. Interviews were conducted with nine selected participants.

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Service; Medical Device; Technology; Manufacturing; Consumer Products; Diagnostic; Chemical


Companies Profiled:
GlaxoSmithKline; ARIAD; Pfizer; Integrated Communications Corp.; Novartis; Genitope Corporation; NeoVista; Inc.; Amgen; Novo Nordisk; Johnson & Johnson; AstraZeneca; Roche; Lilly; Bayer; Human Genome Sciences; Boehringer Ingelheim; Nobel Biocare; Abbott; Solvay Pharmaceuticals; Genentech; Sanofi-aventis; Smith & Nephew; Amylin; Janssen Cilag Pharmaceutical; Dr Reddy's Laboratories; Spectrum Pharmaceutical


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.